Search results
CVS will remove AbbVie's Humira from some drug reimbursement lists in April
Reuters via AOL· 4 months agoCVS Health said on Wednesday it will remove AbbVie’s blockbuster rheumatoid arthritis drug Humira...
Could CVS Make a Copy of Ozempic?
Motley Fool· 8 months agoOn Aug. 23, CVS Health (NYSE: CVS) made waves when it announced that it will be launching a new business called Cordavis that will be devoted to...
CVS Health (CVS) New Opportunities Drive Growth, Macro Woes Stay
Zacks via Yahoo Finance· 4 months agoCVS Health’s CVS restructuring plan, intended to streamline and simplify the organization, looks...
CVS Health will begin manufacturing cheaper 'biosimilar' drugs
Engadget· 8 months agoCVS Health is launching a new subsidiary unit, Cordavis. This new arm will collaborate with drug...
CVS plans to overhaul how drugs are priced
Washington Post via Yahoo Finance· 5 months agoCVS Pharmacy plans to overhaul how it prices prescription drugs, doing away with the complex and often-opaque formulas that typically govern what...
CVS Health (CVS) Launches Caremark Cost Saver With a New Pact
Zacks via Yahoo Finance· 10 months agoCVS Health Corporation’s CVS company, CVS Caremark, partnered with GoodRx to launch Caremark Cost...
Senator seeks answers from CVS over blocking access to low-cost prescriptions
KFOR articles via Yahoo News· 3 months agoU.S. Senator James Lankford, R-OK, wants CVS to answer for its decision to push its own generic...
CVS Health (CVS) Q4 Earnings Top Estimates, 2024 EPS View Down
Zacks via Yahoo Finance· 3 months agoCVS Health Corporation's CVS fourth-quarter 2023 adjusted earnings per share (EPS) of $2.12 rose...
Mark Cuban has a simple question for CVS’s drug middleman: Why don’t you publish your prices?
Ohio Capital Journal via Yahoo News· 1 week agoBusinessman and TV personality Mark Cuban has a seemingly straightforward question for the huge drug...
Zacks Industry Outlook Highlights CVS Health, Herbalife, Rite Aid and Amazon
Zacks via Yahoo Finance· 4 months agoFor Immediate Release Chicago, IL – January 8, 2024 – Today, Zacks Equity Research discusses like...
